Aldeyra Therapeutics Inc (ALDX) Ownership

$5.03

$0.01 (0.2%)
Last update: 12:41 PM EST
Day's range
$4.92
Day's range
$5.13

Aldeyra Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 3.85 M $19.94 M   1.19% 6.40%
VANGUARD GROUP INC 01/29/2026 3.70 M $19.16 M   2.97% 6.15%
KINGDON CAPITAL MANAGEMENT, L.L.C. 02/17/2026 1.85 M $9.58 M   38.91% 3.08%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 1.23 M $6.36 M   -18.50% 2.04%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.17 M $6.06 M   -0.50% 1.95%
STATE STREET CORP 02/13/2026 1.10 M $5.69 M   -0.37% 1.83%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 979.52 K $5.07 M   17.19% 1.63%
MORGAN STANLEY 02/13/2026 657.03 K $3.40 M   -39.35% 1.09%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 612.26 K $3.17 M   -5.57% 1.02%
BANK OF AMERICA CORP /DE/ 02/17/2026 410.03 K $2.12 M   5.11% 0.68%
WELLS FARGO & COMPANY/MN 02/13/2026 366.17 K $1.90 M   1.30% 0.61%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 350.00 K $1.81 M   77.39% 0.58%
DEUTSCHE BANK AG\ 02/11/2026 317.34 K $1.64 M   0.83% 0.53%
GOLDMAN SACHS GROUP INC 02/10/2026 305.71 K $1.58 M   67.10% 0.51%
JANE STREET GROUP, LLC 02/12/2026 303.85 K $1.57 M   20.81% 0.51%
TWO SIGMA INVESTMENTS, LP 02/17/2026 287.36 K $1.49 M   5.24% 0.48%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 268.70 K $1.39 M   231.73% 0.45%
WOODSTOCK CORP 01/14/2026 266.76 K $1.38 M   0.00% 0.44%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 263.41 K $1.36 M   2,382.63% 0.44%
CITADEL ADVISORS LLC 02/17/2026 231.20 K $1.20 M   30.11% 0.38%
1492 CAPITAL MANAGEMENT LLC 02/10/2026 223.32 K $1.16 M   100.00% 0.37%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 152.79 K $791.44 K   1.53% 0.25%
IEQ CAPITAL, LLC 02/13/2026 144.20 K $746.95 K   -9.40% 0.24%
TWO SIGMA ADVISERS, LP 02/17/2026 121.90 K $631.44 K   -33.79% 0.20%
CITADEL ADVISORS LLC 02/17/2026 121.70 K $630.41 K   685.16% 0.20%
BANK OF NEW YORK MELLON CORP 02/10/2026 115.77 K $599.67 K   -4.99% 0.19%
NUVEEN, LLC 02/12/2026 108.22 K $560.58 K   -25.20% 0.18%
GSA CAPITAL PARTNERS LLP 02/06/2026 96.92 K $502.00 K   -20.99% 0.16%
UBS GROUP AG 01/29/2026 95.68 K $495.61 K   -52.34% 0.16%
BARCLAYS PLC 02/13/2026 84.47 K $437.56 K   10.21% 0.14%
GROUP ONE TRADING, L.P. 02/12/2026 83.45 K $432.27 K   -26.53% 0.14%
RHUMBLINE ADVISERS 02/13/2026 70.41 K $364.73 K   -10.47% 0.12%
STRS OHIO 02/02/2026 68.20 K $353.28 K   -20.42% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 62.91 K $325.86 K   -60.28% 0.10%
JANE STREET GROUP, LLC 02/12/2026 57.20 K $296.30 K   67.25% 0.10%
CAPTRUST FINANCIAL ADVISORS 02/17/2026 52.00 K $269.33 K   -1.89% 0.09%
CERITY PARTNERS LLC 02/11/2026 51.05 K $264.43 K   -15.42% 0.08%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 02/03/2026 47.48 K $245.92 K   -2.40% 0.08%
MILLENNIUM MANAGEMENT LLC 02/17/2026 44.06 K $228.23 K   -70.50% 0.07%
CWM, LLC 01/26/2026 43.31 K $224.00 K   -25.82% 0.07%
XTX TOPCO LTD 02/17/2026 42.23 K $218.74 K   22.52% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 42.10 K $218.08 K   100.00% 0.07%
SIMPLEX TRADING, LLC 02/11/2026 39.76 K $205.93 K   36.26% 0.07%
LPL FINANCIAL LLC 02/11/2026 34.92 K $180.87 K   0.00% 0.06%
ALPHACENTRIC ADVISORS LLC 02/12/2026 34.91 K $180.84 K   100.00% 0.06%
INTECH INVESTMENT MANAGEMENT LLC 02/10/2026 33.33 K $172.64 K   57.13% 0.06%
SEI INVESTMENTS CO 02/13/2026 33.29 K $172.43 K   -15.43% 0.06%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 01/08/2026 32.68 K $132.69 K   -0.48% 0.05%
METLIFE INVESTMENT MANAGEMENT, LLC 02/12/2026 29.53 K $152.97 K   60.52% 0.05%
AXQ CAPITAL, LP 02/10/2026 26.81 K $138.88 K   100.00% 0.04%

Aldeyra Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 146 institutional investors and hedge funds held shares of Aldeyra Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 3.85 M

VANGUARD GROUP INC: 3.7 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 1.85 M

AQR CAPITAL MANAGEMENT LLC: 1.23 M

GEODE CAPITAL MANAGEMENT, LLC: 1.17 M

STATE STREET CORP: 1.1 M

64.47% of Aldeyra Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 26.01 M shares in the last 24 months. This purchase volume represents approximately $130.85 M in transactions.